Body mass index and early outcomes following mitral valve surgery for degenerative disease

ObjectiveUsing a large national database, we sought to better define the relationship between obesity measures and early clinical outcomes following mitral valve surgery for degenerative disease.MethodsFor the outcomes of in-hospital mortality, postoperative cerebrovascular event (CVA), and deep sternal wound infection (DSWI), a retrospective cohort study was performed using data acquired from the United Kingdom National Adult Cardiac Surgery Audit. Multivariable Cox proportional hazard regression modeling was used to investigate associations with individual measures of obesity. Progressively adjusted body mass index (BMI)-specific hazard ratios (HRs) were plotted against mean BMI values in each World Health Organization category using floated variances to investigate specific shapes of association.ResultsMultivariable Cox proportional hazard modeling failed to demonstrate an association between mortality and an increase in BMI of 5 points (HR, 0.93, 95% confidence interval [CI], 0.81-1.07), a BMI quintile increase (HR, 0.98; 95% CI, 0.90-1.07), or being classed “obese” by World Health Organization standards (HR, 1.03; 95% CI, 0.74-1.42). A 5-point BMI increase was associated with an increased hazard of DSWI (HR, 1.38; 95% CI, 1.08-1.77) but was not associated with perioperative CVA (HR, 1.05; 95% CI, 0.91-1.21). The shape of association between BMI and mortality appeared approximately U-shaped. DSWI appeared linear, whereas CVA demonstrated an inverted U, or a possible hourglass.ConclusionsAlthough individual measures of obesity were not associated with an increased mortality risk on regression modeling, the U-shaped relationship between mortality and increasing BMI demonstrates lower mortality risks in lower obesity classes. Increasing BMI was associated with an increased hazard for DSWI.     

Asymptomatic degenerative mitral regurgitation repair: Validating guidelines for early intervention

IntroductionMitral repair for asymptomatic (New York Heart Association [NYHA] class I) degenerative mitral regurgitation (MR) is supported by the guidelines, but is not performed often. We sought to determine outcomes for asymptomatic patients when compared with those with symptoms.MethodsBetween 2004 and 2018, 1027 patients underwent mitral replacement (22) or repair with or without other cardiac surgery (1005), the latter being grouped by NYHA class: I (n = 470; 47%), II (n = 408; 40%), or III/IV (n = 127; 13%). Statistical analyses included propensity score matching and weighting, and multistate models.ResultsThe proportion of patients designated as NYHA class I undergoing surgery increased steadily during this period (P < .001). Overall, 30-day mortality was 0.4%, and zero for patients designated NYHA class I. Unadjusted 10-year survival was significantly greater in patients designated NYHA class I compared with II and III/IV (P < .001). Freedom from reoperation at 10 years was 99.8% overall, and 100% for patients designated NYHA class I. In patients designated as NYHA class I, predischarge and 10-year moderate MR were 0.7% and 20.1%, whereas more than moderate was zero and 0.6%. Preoperative ejection fraction less than 60% was associated with late mortality (P = .025). After covariate-adjustments, freedom from MR and tricuspid regurgitation were not statistically significantly different by NYHA class. However, overall survival was significantly worse in patients with NYHA class III/IV, compared with class II.ConclusionsMitral repair in asymptomatic patients is safe and durable. Careful monitoring until class II symptoms is appropriate. However, repair before ejection fraction decreases below 60% is important for late overall survival.     

Leaflet resection for the degenerative mitral valve regurgitation; early/long-term assessment

Leaflet resection for posterior leaflet prolapse has been a standard repair procedure with good longterm durability. The aim of this study was to review our experience of mitral valve repair, in which resection of the anterior and/or posterior leaflets was performed. Between October 1991 and December 2010, 172 patients with degenerative mitral valve regurgitation underwent mitral valve reconstruction,including 98 patients with the posterior leaflet prolapse, 47 patients with the anterior leaflet prolapse, 17 patients with both leaflets and 10 patients with the commissure prolapse. Most patients in this study were supposed to be caused by fibroelastic deficiency and we have not experienced systolic anterior motion after repair. The mean follow-up period was 8.7 ± 5.5 years. The freedom from reoperation rates at 15 years in 88.7 ± 5.3% of the anterior leaflet procedure, 96.6 ± 2.5% of the posterior leaflet, and 100% of both leaflets. The results of resection of a diseased prolapsed mitral leaflet have been promising so far. However, reoperation was required in 7 patients (4.1%) and reoperation rate was higher in patients with anterior prolapse and longer follow-up will evaluate precisely be benefit.     

Outcomes of mitral valve repair for mitral regurgitation due to degenerative disease

The aim of this study was to review the clinical and echocardiographic outcomes after mitral valve repair for mitral regurgitation due to degenerative disease of the mitral valve. A total of 649 consecutive patients who had isolated mitral valve repair were prospectively followed up for 6.8 +/- 3.1 years. The mean age was 58 +/- 11 years. The operative mortality rate was 0.6%; the late mortality rate was 14.6%; and survival at 15 years was 67 +/- 5%. Age by increments of 5 years, advanced functional class, and impaired left ventricular function were independent predictors of late death. The freedom from reoperation on the mitral valve at 15 years was 92 +/- 3%, and the freedom from late, recurrent, severe mitral regurgitation was 85 +/- 4%. Most patients were in functional classes I or II at the latest follow-up contact. Mitral valve repair is associated with low operative mortality and morbidity, but it does not arrest the degenerative process. This study suggests that rates of reoperation underscore rates of late failure of the mitral valve repair.     

Intraoperative TEE assessment during mitral valve repair for degenerative and ischemic mitral valve regurgitation

Intraoperative assessment of the mitral valve (MV) in patients undergoing repair for MV regurgitation is a valuable support for the cardiac surgical team; results can be favored by adequate assessment tailored to the main condition affecting the MV. This article will review current available data for assessment of the MV in degenerative and ischemic mitral regurgitation.     

Reconstructive surgery for mitral and tricuspid valves--principles and personal experience

We have experienced 246 cases of reconstructive surgery for mitral and tricuspid valves, with 17 deaths in the immediate post-operative period or during follow-up. This gives an overall mortality rate of 6.9 per cent whereas in 72 cases of mitral valve reconstruction we recorded only 2 deaths i.e. a mortality rate of 2.7 per cent although the post-operative period remains relatively short. Thus, we feel fully justified in pursuing our conservative surgery program, especially for younger patients who, given their superior myocardial state, can lead a fuller life after mitral reconstruction than after mitral replacement. It is our conviction that mitral and tricuspid valve reconstruction should not be overlooked and that prior to resection and replacement, the surgeon and the team should pause and scrupulously examine the valvular components with a view to conservative surgery. For certain lesions, reconstruction can be carried out rapidly and reliably. The mortality rate is not higher than conventional cardiac surgery and the patient's long term prognosis is considerably improved.     

Repair of mitral regurgitation caused by prolapse of the anterior mitral leaflet

Mitral regurgitation caused by prolapse of the anterior mitral leaflet has been considered to be difficult for reconstruction. In Japan, these cases have been repaired mainly by replacement of chordae with artificil sutures. We have repaired them by Carpentier’s technique. We report a series of 9 patients with pure mitral regurgitation caused by ruptured or elongated chordae of the anterior mitral leaflet. Two of them had lesions at both anterior and posterior leaflet. All patients underwent mitral valve repair by segmental transposition of the posterior leaflet. As for associated procedures, there were ring annuloplasty with Carpenter rings (9 cases), sliding technique (8 cases) reported by Carpentier, reinforcement by transposition of secondary chordae of the posterior leaflet (6 cases), commissuroplasty (1 case), and closure of leaflet perforation. All patients survived operations and all patients except one underwent left ventriculography postoperatively. In only 2 patients, residual mitral regurgitatin classed as I/IV was observed. All patients returned home in New York Heart Association class I. Follow-up ranged from 7 to 45 months (mean follow-up 20 months). All patients were free from reoperation or thromboembolism. Although longer follow-up is necessary, this technique appears to be adequate for the repir of patients with anterior leaflet prolapse.     

Clinical outcomes of surgery of mitral valve regurgitation and coronary artery bypass grafting

The impact of etiology of associated mitral valve regurgitation and a valve procedure on operative and long-term outcomes after coronary bypass grafting surgery is yet to be clearly defined. Results of combined coronary artery bypass grafting and valve procedures for mitral valve regurgitation were retrospectively analyzed in 468 patients. The regurgitation was of ischemic in 45%, degenerative in 55% and 78% valve repairs, 22% valve replacements were performed. Severe coronary artery disease, acute myocardial infarction, low ejection fraction, ischemic mitral regurgitation, advanced heart failure symptoms, failure to use internal mammary artery, valve replacement surgery, and emergency operations are predictors of operative mortality. The 5-year survivals for propensity-matched patients of ischemic and degenerative disease were similar (66%), but 67% vs. 83%, respectively, for unmatched patients. Low ejection fraction (<35%), advanced age (>67 years), valve replacement surgery, residual mitral regurgitation, and severe coronary artery disease were predictors of poor long-term survival. Left ventricular remodeling processes, optimal valve procedure without residual mitral regurgitation and left ventricular function are important determinants of long-term outcome than the etiology of valve regurgitation.     

Mitral regurgitation caused by an isolated mitral leaflet cleft

An isolated cleft of the mitral valve leaflet is rare cause of mitral regurgitation in adults. We report a successful minimally invasive mitral valve repair for severe mitral regurgitation caused by an isolated cleft of the anterior mitral leaflet. During the operation, we found a large cleft measuring 5×8 mm in the center of the anterior mitral leaflet. We closed the cleft directly and performed annuloplasty with a 30-mm Carpenter-Edwards Physio Ring (Edwards Lifesciences, Irvine, CA). The mitral valve is very well visualized with the video-assisted minimally invasive approach through the right chest.     

Mitral valve surgery for chronic ischemic mitral regurgitation

BACKGROUND: Early and midterm clinical and echocardiographic results after mitral valve (MV) surgery for chronic ischemic mitral regurgitation were investigated to evaluate the validity of the criteria for repair or replacement applied by us. METHODS: From 1988 to 2002, 102 patients with ischemic mitral regurgitation underwent MV surgery (82 repairs and 20 replacements). End-systolic distance between the coaptation point of mitral leaflets and the plane of mitral annulus was the key factor that allowed either repair (10 mm). Patients who had MV replacement showed higher New York Heart Association class (3.2 +/- 0.5 versus 3.4 +/- 0.5; p = 0.016), lower preoperative ejection fraction (0.33 +/- 0.9 versus 0.38 +/- 0.12; p = 0.034), and higher end-diastolic volume (161 +/- 69 mL versus 109 +/- 35 mL; p < 0.001) compared with repair. Mitral regurgitation was 3.2 +/- 0.7 in both groups. RESULTS: Thirty-day mortality was 3.9% (2.4% MV repair versus 10.0% MV replacement; not significant). During the follow-up 26 patients died. Of the 72 survivors, 55 (76.3%) were in New York Heart Association classes I and II. Five-year survival was 75.6% +/- 4.7% in MV repair and 66.0% +/- 10.5% in MV replacement (not significant). Survival in New York Heart Association classes I and II was 58.9% +/- 5.4% in MV repair and 40.0% +/- 11.0% in MV replacement (not significant). Cox analysis identified preoperative New York Heart Association class, ejection fraction, end-diastolic volume, end-systolic volume, and congestive heart failure as risk factors common to both events. In 46 patients, late echocardiograms showed no volume or ejection fraction modifications. In patients who underwent MV repair, 50% had no or mild mitral regurgitation. CONCLUSIONS: Correction of chronic ischemic mitral regurgitation through either repair or replacement provides a good 5-year survival rate, with more than 75% of the survivors in New York Heart Association classes I and II.     

Indications for surgery in degenerative mitral valve disease

There has been great progress during the past decade in management of patients with mitral regurgitation. Doppler echocardiography allows accurate quantification of the degree of valve leakage and tracking of the effect of regurgitation on cardiac size and function. Natural history studies have clearly delineated the deleterious effects of severe, persistent mitral valve regurgitation including an increased risk of cardiac death as well as a predisposition to the development of congestive heart failure and atrial fibrillation. In virtually all of our analyses, short-term and long-term outcomes are improved in patients who have early surgical correction of severe mitral valve regurgitation. Moreover, there are clear benefits of mitral valve repair over valve replacement, including greater regression of left heart dimensions, normalization of left ventricular function, and superior long-term survival.     

Survival and durability of mitral valve repair surgery for degenerative mitral valve disease

Abstract Aim of the study: To evaluate the results after standardized techniques of mitral valve repair (MVr) for treatment of degenerative mitral regurgitation (MR) and to analyze risk factors for late outcomes. Methods: Two hundred and sixty‐one patients (mean age 63 ± 12 years) underwent MVr between January 1999 and January 2010 for degenerative MR. In the last five years, all repair techniques were performed routinely using annuloplasty prosthetic ring, with or without quadrangular or triangular resection of posterior leaflet and/or edge‐to‐edge technique as always indicated by intraoperative transesophageal echocardiography. Mean follow‐up (99% complete) was 54 ± 38 (range, 6 to 137) months. Results: Operative mortality was 0.8% (2/261), 10‐year actuarial survival 89%± 3%. At 10 years of follow‐up freedom from cardiac death was 94%± 2.6%, from reoperation 95%± 2.4%, from thromboembolism 96%± 2.1%, and from endocarditis 100%. Independent predictor of late all‐causes mortality was advanced age at operation (71 ± 10 years vs. 62 ± 12 years, p = 0.0068). Late progression to moderate or severe MR was observed in 12/256 patients (4.7%). Independent predictor of late progression to moderate or severe MR was annuloplasty without the use of prosthetic ring (p = 0.04). Reoperation was required in six patients (2.3%). Follow‐up echocardiography showed improvement of MR, left ventricular end‐diastolic and end‐systolic diameters, left atrial diameter, and systolic pulmonary artery pressure (p < 0.0001 for all comparisons with preoperative values). Conclusions: MVr is a low‐risk, durable surgical procedure. Standardized techniques, with the routine use of prosthetic ring, improve late results. (J Card Surg 2011;26:360‐366)     

Reconstructive surgery for mitral and tricuspid valves —Principles and personal experience

We have experienced 246 cases of reconstructive surgery for mitral and tricuspid valves, with 17 deaths in the immediate post-operative period or during follow-up. This gives an overall mortality rate of 6.9 per cent whereas in 72 cases of mitral valve reconstruction we recorded only 2 deaths i.e. a mortality rate of 2.7 per cent although the post-operative period remains relatively short. Thus, we feel fully justified in pursuing our conservative surgery program, especially for younger patients who, given their superior myocardial state, can lead a fuller life after mitral reconstruction than after mitral replacement. It is our conviction that mitral and tricuspid valve reconstruction should not be overlooked and that prior to resection and replacement, the surgeon and the team should pause and scrupulously examine the valvular components with a view to conservative surgery. For certain lesions, reconstruction can be carried out rapidly and reliably. The mortality rate is not higher than conventional cardiac surgery and the patient’s long term prognosis is considerably improved.